LINE-1 ORF1 Protein Is Up-regulated by reactive Oxygen species and associated with bladder urothelial carcinoma progression

Cancer Genomics and Proteomics

Volumn 15, Issue 2, 2018, Pages 143-151

  Whongsiri, Patcharawalai ^a   Pimratana, Chaowat ^b   Wijitsettakul, Udomsak ^b   Jindatip, Depicha ^c   Sanpavat, Anapat ^a   Schulz, Wolfgang A ^d   Hoffmann, MicheLe J ^d   Goering, Wolfgang ^e   Boonla, Chanchai ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Buri Ram Hospital   (Thailand)

^c Departments of Anatomy   (Australia)

^d Departments of Urology   (United States)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

4 HNE; Bladder Cancer; Cancer Progression; Immunohistochemistry; LINE 1; ORF1p; Oxidative Stress

Indexed keywords

4 HYDROXYNONENAL; HYDROGEN PEROXIDE; ORF1P PROTEIN; PROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; ORF1 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL MIGRATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN INDUCTION; TCCSUP CELL LINE; TRANSITIONAL CELL CARCINOMA; UM-UC-3 CELL LINE; UPREGULATION; VM-CUB-1 CELL LINE; AGED; BLADDER TUMOR; CELL MOTION; DISEASE EXACERBATION; GENETICS; LONG INTERSPERSED REPEAT; METABOLISM; PATHOLOGY; PHYSIOLOGY;

AGED; CELL MOVEMENT; DISEASE PROGRESSION; FEMALE; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; PROTEINS; REACTIVE OXYGEN SPECIES; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 85044502792     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: 10.21873/cgp.20072     Document Type: Article

References (30)

1. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann Y, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, Gibbs RA, Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Raymond C, Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, Blocker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowki J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A, Wetterstrand KA, Patrinos A, Morgan MJ, de Jong P, Catanese JJ, Osoegawa K, Shizuya H, Choi S, Chen YJ, Szustakowki J and International Human Genome Sequencing C: Initial sequencing and analysis of the human genome. Nature 409: 860-921, 2001.
2. Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV and Kazazian HH, Jr: Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci USA 100: 5280-5285, 2003.
3. Beck CR, Collier P, Macfarlane C, Malig M, Kidd JM, Eichler EE, Badge RM and Moran JV: LINE-1 retrotransposition activity in human genomes. Cell 141: 1159-1170, 2010.
4. Doucet-O'Hare TT, Rodic N, Sharma R, Darbari I, Abril G, Choi JA, Young Ahn J, Cheng Y, Anders RA, Burns KH, Meltzer SJ and Kazazian HH Jr.: LINE-1 expression and retrotransposition in Barrett's esophagus and esophageal carcinoma. Proc Natl Acad Sci USA 112: E4894-4900, 2015.
5. Rodic N and Burns KH: Long interspersed element-1 (LINE-1): Passenger or driver in human neoplasms PLoS Genet 9: E1003402, 2013.
6. Taylor MS, LaCava J, Mita P, Molloy KR, Huang CR, Li D, Adney EM, Jiang H, Burns KH, Chait BT, Rout MP, Boeke JD and Dai L: Affinity proteomics reveals human host factors implicated in discrete stages of LINE-1 retrotransposition. Cell 155: 1034-1048, 2013.
7. Ardeljan D, Taylor MS, Ting DT and Burns KH: The human long interspersed element-1 retrotransposon: An emerging biomarker of neoplasia. Clin Chem 63: 816-822, 2017.
8. Rodic N, Sharma R, Sharma R, Zampella J, Dai L, Taylor MS, Hruban RH, Iacobuzio-Donahue CA, Maitra A, Torbenson MS, Goggins M, Shih Ie M, Duffield AS, Montgomery EA, Gabrielson E, Netto GJ, Lotan TL, De Marzo AM, Westra W, Binder ZA, Orr BA, Gallia GL, Eberhart CG, Boeke JD, Harris CR and Burns KH: Long interspersed element-1 protein expression is a hallmark of many human cancers. Am J Pathol 184: 1280-1286, 2014.
9. Kitkumthorn N and Mutirangura A: Long interspersed nuclear element-1 hypomethylation in cancer: Biology and clinical applications. Clin Epigenetics 2: 315-330, 2011.
10. Falso MJ, Buchholz BA and White RW: Stem-like cells in bladder cancer cell lines with differential sensitivity to cisplatin. Anticancer Res 32: 733-738, 2012.
11. Jurgens B, Schmitz-Drager BJ and Schulz WA: Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. Cancer Res 56: 5698-5703, 1996.
12. Florl AR, Lower R, Schmitz-Drager BJ and Schulz WA: DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br J Cancer 80: 1312-1321, 1999.
13. Chalitchagorn K, Shuangshoti S, Hourpai N, Kongruttanachok N, Tangkijvanich P, Thong-ngam D, Voravud N, Sriuranpong V and Mutirangura A: Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23: 8841-8846, 2004.
14. Patchsung M, Boonla C, Amnattrakul P, Dissayabutra T, Mutirangura A and Tosukhowong P: Long interspersed nuclear element-1 hypomethylation and oxidative stress: Correlation and bladder cancer diagnostic potential. PLoS One 7: E37009, 2012.
15. Kloypan C, Srisa-art M, Mutirangura A and Boonla C: LINE-1 hypomethylation induced by reactive oxygen species is mediated via depletion of S-adenosylmethionine. Cell Biochem Funct 33: 375-385, 2015.
16. Wongpaiboonwattana W, Tosukhowong P, Dissayabutra T, Mutirangura A and Boonla C: Oxidative stress induces hypomethylation of LINE-1 and hypermethylation of the RUNX3 promoter in a bladder cancer cell line. Asian Pac J Cancer Prev 14: 3773-3778, 2013.
17. Evans PJ, Whiteman M, Tredger JM and Halliwell B: Antioxidant properties of S-adenosyl-L-methionine: A proposed addition to organ storage fluids. Free Radic Biol Med 23: 1002-1008, 1997.
18. Ma-On C, Sanpavat A, Whongsiri P, Suwannasin S, Hirankarn N, Tangkijvanich P and Boonla C: Oxidative stress indicated by elevated expression of Nrf2 and 8-OHdG promotes hepatocellular carcinoma progression. Med Oncol 34: 57, 2017.
19. Sesti F, Tsitsilonis OE, Kotsinas A and Trougakos IP: Oxidative stress-mediated biomolecular damage and inflammation in tumorigenesis. In Vivo 26: 395-402, 2012.
20. Xiao-Jie L, Hui-Ying X, Qi X, Jiang X and Shi-Jie M: LINE-1 in cancer: Multifaceted functions and potential clinical implications. Genet Med 18: 431-439, 2016.
21. Fiaschi T and Chiarugi P: Oxidative stress, tumor microenvironment, and metabolic reprogramming: A diabolic liaison. Int J Cell Biol 2012: 762825, 2012.
22. Carini F, Mazzola M, Rappa F, Jurjus A, Geagea AG, Al Kattar S, Bou-Assi T, Jurjus R, Damiani P, Leone A and Tomasello G: Colorectal carcinogenesis: Role of oxidative stress and antioxidants. Anticancer Res 37: 4759-4766, 2017.
23. Kreimer U, Schulz WA, Koch A, Niegisch G and Goering W: HERV-K and LINE-1 DNA methylation and reexpression in urothelial carcinoma. Front Oncol 3: 255, 2013.
24. Boissinot S, Chevret P and Furano AV: L1 (LINE-1) retrotransposon evolution and amplification in recent human history. Mol Biol Evol 17: 915-928, 2000.
25. Sassaman DM, Dombroski BA, Moran JV, Kimberland ML, Naas TP, DeBerardinis RJ, Gabriel A, Swergold GD and Kazazian HH Jr.: Many human L1 elements are capable of retrotransposition. Nat Genet 16: 37-43, 1997.
26. Philippe C, Vargas-Landin DB, Doucet AJ, van Essen D, Vera-Otarola J, Kuciak M, Corbin A, Nigumann P and Cristofari G: Activation of individual L1 retrotransposon instances is restricted to cell-type dependent permissive loci. Elife 5: E13926, 2016.
27. Nusgen N, Goering W, Dauksa A, Biswas A, Jamil MA, Dimitriou I, Sharma A, Singer H, Fimmers R, Frohlich H, Oldenburg J, Gulbinas A, Schulz WA and El-Maarri O: Inter-locus as well as intra-locus heterogeneity in LINE-1 promoter methylation in common human cancers suggests selective demethylation pressure at specific CpGs. Clin Epigenetics 7: 17, 2015.
28. Liou GY and Storz P: Reactive oxygen species in cancer. Free Radic Res 44: 479-496, 2010.
29. Panieri E and Santoro MM: ROS homeostasis and metabolism: A dangerous liason in cancer cells. Cell Death Dis 7: E2253, 2016.
30. Mahalingaiah PK, Ponnusamy L and Singh KP: Oxidative stressinduced epigenetic changes associated with malignant transformation of human kidney epithelial cells. Oncotarget 8: 11127-11143, 2017.